Evidence map›Paper›PMID 25892034›Full record

ArticleBiometrics2015

Quantile regression with a change-point model for longitudinal data: An application to the study of cognitive changes in preclinical alzheimer's disease.

Chenxi Li, N Maritza Dowling, Rick Chappell

Open access · greenAbstract read
In one paragraph

Article in Biometrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Embracing non-linearity in human ageing.Nature reviews. Genetics · 2026
    Review
  3. Article
  4. Observational
  5. Education and Cognitive Functioning Across the Life Span.Psychological science in the public interest : a journal of the American Psychological Society · 2020
    Review
  6. Review
  7. Article
  8. Neurology · 2017
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Chenxi LiDepartment of Epidemiology and Biostatistics, Michigan State University, East Lansing, Michigan 48824, U.S.A.
N Maritza DowlingDepartment of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin 53792, U.S.A.
Rick ChappellDepartment of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin 53792, U.S.A.
University of Wisconsin–Madison · USMichigan State University · US

Funding

SUPPLEMENT TO RUSH ALZHEIMERS DISEASE CENTER COREP30AG010161 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI LEURGANS, SUE E. · 1991 to 2020
$49.1M
EPIDEMIOLOGY OF NEURAL RESERVE AND NEUROBIOLOGY IN AGINGR01AG017917 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 2001 to 2023
$43.3M
RISK FACTORS, PATHOLOGY, AND CLINICAL EXPRESSIONS OF ADR01AG015819 · NIA · RUSH UNIVERSITY MEDICAL CENTER · PI BENNETT, DAVID ALAN · 1998 to 2024
$21.4M
Wisconsin Alzheimer's Disease Research CenterP50AG033514 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI SAGER, MARK · 2009 to 2018
$16.2M
NIA NIH HHS 5 P50 AG033514-05NIA NIH HHS P30 AG010161NIA NIH HHS P30AG10161NIA NIH HHS P50 AG033514NIA NIH HHS R01 AG015819NIA NIH HHS R01 AG017917NIA NIH HHS R01AG15819NIA NIH HHS R01AG17917
6 · The paper itself

Abstract

Progressive and insidious cognitive decline that interferes with daily life is the defining characteristic of Alzheimer's disease (AD). Epidemiological studies have found that the pathological process of AD begins years before a clinical diagnosis is made and can be highly variable within a given population. Characterizing cognitive decline in the preclinical phase of AD is critical for the development of early intervention strategies when disease-modifying therapies may be most effective. In the last decade, there has been an increased interest in the application of change-point models to longitudinal cognitive outcomes prior to and after diagnosis. Most of the proposed statistical methodology for describing decline relies upon distributional assumptions that may not hold. In this article, we introduce a quantile regression with a change-point model for longitudinal data of cognitive function in persons bound to develop AD. A change-point in our model reflects the transition from the cognitive decline due to normal aging to the accelerated decline due to disease progression. Quantile regression avoids common distributional assumptions on cognitive outcomes and allows the covariate effects and the change-point to vary for different quantiles of the response. We provided an approach for estimating the model parameters, including the change-point, and presented inferential procedures based on the asymptotic properties of the estimators. A simulation study showed that the estimation and inferential procedures perform reasonably well in finite samples. The practical use of our model was illustrated by an application to longitudinal episodic memory outcomes from two cohort studies of aging and AD.

Indexed as

Longitudinal StudiesRegression AnalysisAge DistributionAlzheimer DiseaseCognition DisordersComorbidityData Interpretation, StatisticalHumansIncidenceReproducibility of ResultsRisk AssessmentSensitivity and SpecificityAlzheimer's diseaseChange-point modelCognitive agingDisease progressionLongitudinal dataQuantile regression

Identifiers

PMID25892034
PMCPMC4575281
OpenAlexW2102015455

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.